New diabetes drug shows promise in phase 3 trial
Disease control
Completed
This study tested a new medicine called XW003 in 211 adults with type 2 diabetes whose blood sugar was not well managed by diet and exercise alone. Participants received either XW003 or a placebo (dummy pill) to see if the drug could safely lower blood sugar levels. The main goal…
Phase: PHASE3 • Sponsor: Hangzhou Sciwind Biosciences Co., Ltd. • Aim: Disease control
Last updated May 17, 2026 09:19 UTC